alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › wait-times

wait-times

2 studies tagged wait-times, dated 2023-11-06 to 2024-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times 2024-01-01
  2. Expected wait times for access to a disease-modifying Alzheimer's treatment in England: A modelling study 2023-11-06

Studies

2 studies carry this tag.

Date range

2023 to 2024

Top journals

  • Journal of Alzheimer's disease : JAD 1
  • Journal of health services research & policy 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2024-01-01 Biomarkers

    In spite of having a well-resourced health system, Germany is projected to be unable to cope with the demand for biomarker-based AD diagnosis, if a disease-modifying AD treatment were introduced.

  2. Expected wait times for access to a disease-modifying Alzheimer's treatment in England: A modelling study

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of health services research & policy 2023-11-06 Biomarkers

    The NHS England lacks capacity to provide timely access to a disease-modifying treatment, which is estimated to result in significant wait times and potentially avoidable disease progression.

All topic tags with their study counts